Application of the 2013 American College of Cardiology/American Heart Association Cholesterol Guideline to the Korean National Health and Nutrition Examination Surveys from 1998 to 2012.
- Author:
Young Shin SONG
1
;
Tae Jung OH
;
Kyoung Min KIM
;
Jae Hoon MOON
;
Sung Hee CHOI
;
Hak Chul JANG
;
Kyong Soo PARK
;
Soo LIM
Author Information
- Publication Type:Original Article
- Keywords: American Heart Association; Atherosclerosis; Cardiovascular disease; Guideline; Korea
- MeSH: Adult; American Heart Association; Atherosclerosis; Cardiovascular Diseases; Cholesterol*; Cholesterol, LDL; Heart*; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Korea; Nutrition Surveys; Prevalence
- From:Diabetes & Metabolism Journal 2017;41(1):38-50
- CountryRepublic of Korea
- Language:English
- Abstract: BACKGROUND: The 2013 American College of Cardiology/American Heart Association (ACC/AHA) guideline for the treatment of blood cholesterol recommends statin therapy for individuals at high risk of atherosclerotic cardiovascular disease (ASCVD). The aim of this study was to investigate serial trends in the percentages of Korean adults considered eligible for statin therapy according to the new ACC/AHA cholesterol guideline. METHODS: Data from the Korean National Health and Nutrition Examination Survey (KNHANES) I (1998, n=7,698), II (2001, n=5,654), III (2005, n=5,269), IV (2007 to 2009, n=15,727), and V (2010 to 2012, n=16,304), which used a stratified, multistage, probability sampling design, were used as representative of the entire Korean population. RESULTS: The percentage of adults eligible for statin therapy according to the ACC/AHA cholesterol guideline increased with time: 17.0%, 19.0%, 20.8%, 20.2%, and 22.0% in KNHANES I, II, III, IV, and V, respectively (P=0.022). The prevalence of ASCVD was 1.4% in KNHANES I and increased to 3.3% in KNHANES V. The percentage of diabetic patients aged 40 to 75 years with a low density lipoprotein cholesterol levels of 70 to 189 mg/dL increased from 4.8% in KNHANES I to 6.1% in KNHANES V. People with an estimated 10-year ASCVD risk ≥7.5% and aged 40 to 75 years accounted for the largest percentage among the four statin benefit groups: 9.1% in KNHANES I and 11.0% in KNHANES V. CONCLUSION: Application of the 2013 ACC/AHA guideline has found that the percentage of Korean adults in the statin benefit groups has increased over the past 15 years.
